authors
- Piccart, M
- Hortobagyi, GN
- Campone, M
- Pritchard, Kathleen
- Noguchi, S
- Rugo, H
- Gnant, M
- Feng, W
- Taran, T
- Baselga, J
1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2
Conference Paper
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2014
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal
presented at event
- 9th European Breast Cancer Conference (EBCC) Conference